http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
CerTest Biotec, BD Announce Addition of Saliva to the CE Marked VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit for BD MAX™ Molecular Diagnostic System
-
Becton Dickinson (BDX) Reports FDA 510(k) Submission for BD Alaris System
-
BD Announces FDA 510(k) Submission for BD Alaris™ System
-
USATF Partners With BD To Provide Rapid COVID-19 Testing To Enhance Athlete Safety At Track & Field Events
-
BD's Commitment to Address Climate Change
-
BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
-
BD Commits $1M To Fight Maternal And Neonatal Tetanus
-
Becton Dickinson (BDX) Granted FDA 510(k) Clearance of Pristine Long-Term Hemodialysis Catheter
-
BD Announces 510(k) Clearance of Pristine™ Long-Term Hemodialysis Catheter
-
BD MAX™ Molecular Multi-Drug Resistant Tuberculosis Test To Be Included In WHO Updated Consolidated Guidelines On Tuberculosis
-
BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021
-
Becton Dickinson (BDX) to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply
-
BD to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply
-
BD Receives Emergency Use Authorization for Asymptomatic Screening for SARS-CoV-2 through Serial Rapid Antigen Testing
-
Becton Dickinson (BDX) Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test
-
BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test
-
Becton Dickinson (BDX) Announces Collaboration with ImageMover for Rapid Antigen Test Reporting
-
BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting
-
Becton Dickinson (BDX) Acquires GSL Solutions
-
BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings
-
Becton Dickinson (BDX) Announces Collaboration for At-Home Rapid Test for COVID-19
-
BD Announces Collaboration for At-Home Rapid Test for COVID-19
-
BD to Present at Upcoming Investor Conferences
-
Becton Dickinson (BDX) Announces EUA, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
-
BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
-
BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance
-
Musk questions coronavirus tests, saying they gave opposite results on same day
-
Henry Schein (HSIC) Provides Updates on Efforts to Address the COVID-19 Pandemic
-
Henry Schein Announces Further Efforts to Address the COVID-19 Pandemic
-
S&P 500, Dow ease from record highs after three-day rally
-
Wall St. reaches new highs as China moves to limit coronavirus impact
-
BD Launches Enhanced Antimicrobial Stewardship Analytics Capabilities
-
Community Clinics Receive Grant for Point-of-Care Diagnostics
-
BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes
-
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution
-
BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals' Greatest Challenges at #ASHP17
-
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
-
MedMined® Surveillance Advisor Wins 2015/2016 KLAS Category Leader Award
-
BD Utilizes AT&T Connectivity To Offer Connected Wireless Health Devices
-
Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges
-
CareFusion AirLife Signs New Distribution Agreement with ResMed
-
BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis
-
Trading Radar for 2/4: Twitter (TWTR), GoPro (GPRO), LinkedIn (LNKD), Kors (KORS), Philip Morris (PM) Report

